88.13 +0.04 (0.05%)
Pre-market: 5:43AM EDT
|Bid||88.09 x 900|
|Ask||89.99 x 1000|
|Day's range||86.30 - 88.12|
|52-week range||39.29 - 88.88|
|Beta (5Y monthly)||1.56|
|PE ratio (TTM)||11.52|
|Earnings date||14-Jul-2021 - 19-Jul-2021|
|Forward dividend & yield||1.40 (1.59%)|
|1y target est||91.72|
Investment firm ValueAct liquidated its stake in Morgan Stanley and trimmed holdings in Citigroup Inc, KKR & Co Inc and SLM Corp in early 2021, pointing to a shift away from some financial firms that it has owned for several years, a regulatory filing released on Monday showed. ValueAct sold 8.2 million shares of U.S. bank Morgan Stanley stock during the first quarter, exiting the remainder of an investment it first told clients about in 2016. At that time ValueAct said it owned 38 million shares worth $1.1 billion.
Morgan Stanley Investment Management ("MSIM") and CastleOak Securities, L.P. ("CastleOak"), an industry-leading, minority-owned, boutique investment bank are pleased to announce an expansion of their long-standing partnership by debuting two new co-branded share class offerings that provide clients an expanded menu of short-term cash investment services. As clients increasingly look to maximize their social impact, these two new products provide a solution that brings together CastleOak’s strong institutional relationships and Morgan Stanley’s unparalleled investment experience.
ValGenesis, Inc. ("ValGenesis"), the market leader in Enterprise Validation Lifecycle Management Systems (VLMS), announced the closing of a $24 million investment from Morgan Stanley Expansion Capital. Proceeds will bolster sales and accelerate ValGenesis’ focus on innovation in digital validation technologies and global deployment.